Long-term outcomes of EVALI: a 1-year retrospective study

被引：9
|
作者：
Triantafyllou, Georgios A. [1 ]
Tiberio, Perry J. [1 ]
Zou, Richard H. [1 ]
Lynch, Michael J. [1 ,2 ]
Kreit, John W. [1 ]
McVerry, Bryan J. [1 ]
Morris, Alison [1 ]
Rose, Jason J. [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA 15261 USA
来源：
LANCET RESPIRATORY MEDICINE | 2021年 / 9卷 / 12期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/S2213-2600(21)00415-X
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：E112 / E113
页数：2
相关论文
共 50 条
  • [1] Long-Term Safety of Fremanezumab: Results of a 1-Year Study
    Ning, Xiaoping
    Cohen, Joshua
    Bennett, Nathan
    Yeung, Paul
    Yang, Ronghua
    [J]. NEUROLOGY, 2019, 92 (15)
  • [2] HYDERGINE IN A LONG-TERM STUDY OVER A 1-YEAR PERIOD
    CHIERICHETTI, S
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE, 1983, 16 (06): : 311 - 312
  • [3] Long-Term Safety of Fremanezumab: Results of a 1-Year Study
    Ning, X.
    Cohen, J. M.
    Bennett, N. L.
    Yang, R.
    [J]. HEADACHE, 2019, 59 : 47 - 47
  • [4] Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study
    Balanza-Martinez, Vicent
    [J]. BIPOLAR DISORDERS, 2022, 24 : 23 - 23
  • [5] Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study
    Mendez, Raul
    Balanza-Martinez, Vicent
    Luperdi, Sussy C.
    Estrada, Itziar
    Latorre, Ana
    Gonzalez-Jimenez, Paula
    Bouzas, Leyre
    Yepez, Katheryn
    Ferrando, Ana
    Reyes, Soledad
    Menendez, Rosario
    [J]. JOURNAL OF INTERNAL MEDICINE, 2022, 291 (02) : 247 - 251
  • [6] The long-term tolerability and efficacy of OESCLIM®:: results of a 1-year study
    Taurelle, R
    L'Hermite, M
    Haenggi, W
    Lauritzen, C
    Studd, JW
    [J]. MATURITAS, 1999, 33 : S73 - S81
  • [7] DOES DEPRESSION IMPACT COMMUNITY LONG-TERM CARE OUTCOMES AFTER 1-YEAR?
    Hasche, L.
    Morrow-Howell, N.
    Proctor, E.
    [J]. GERONTOLOGIST, 2008, 48 : 105 - 106
  • [8] Long-Term Impact of Fremanezumab on Response Rates: Results of a 1-Year Study
    Newman, Lawrence
    Cohen, Joshua
    Yeung, Paul
    Yang, Ronghua
    Ning, Xiaoping
    [J]. NEUROLOGY, 2019, 92 (15)
  • [9] Long-Term Efficacy and Safety of Fremanezumab in Migraine: Results of a 1-Year Study
    Goadsby, Peter
    Monteith, Teshamae
    Yeung, Paul P.
    Cohen, Joshua
    Yang, Ronghua
    [J]. NEUROLOGY, 2019, 92 (15)
  • [10] Long-Term Impact of Fremanezumab on Response Rates: Results of a 1-Year Study
    Newman, L. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 103 - 104
12345